ROBERT BRITTON to Antineoplastic Agents
This is a "connection" page, showing publications ROBERT BRITTON has written about Antineoplastic Agents.
Connection Strength
0.115
-
Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics*. ChemMedChem. 2021 04 08; 16(7):1116-1125.
Score: 0.087
-
Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide. Mol Cancer Ther. 2004 Oct; 3(10):1221-7.
Score: 0.028